Clin2
NCT07227428Likely a fitNot yet recruiting

Comparing ways to lower steroids in rheumatoid arthritis

Rheumatoid Arthritis (RA)

Treatments studied

Part of Bones, joints & muscles, Hormones & metabolism, Immune system & allergy, Skin clinical trials.

This study tests two ways of slowly lowering your steroid dose (prednisolone) to see which is safer and works better for people with stable rheumatoid arthritis. You may join if you have been on a low, steady dose of steroids and your arthritis is well controlled.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
206 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years old or older
  • Your weight is under 90 kg (about 198 pounds)
  • You have had rheumatoid arthritis for at least 6 months
  • Your arthritis has been stable (no flare-ups) for the past 4 weeks
  • You have been taking a low, steady dose of a steroid called prednisolone (5 mg or less per day) for at least 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07268326Recruiting
Plant-based diet for rheumatoid arthritis

This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.

Frederiksberg
NCT07182630Not yet recruiting
Study of RA drugs: Anti-TNF vs non-TNF drugs

This trial looks at how two types of rheumatoid arthritis (RA) medications affect patients. It aims to compare anti-TNF drugs with other RA drugs to see if one type is better.

Elâzığ
NCT07245732Recruiting· Phase 4
Steroid pills vs. shots for rheumatoid arthritis flares

This trial compares steroid pills to steroid shots for controlling sudden worsening of rheumatoid arthritis symptoms. It aims to find which method works better and is easier for you.

Toronto, Ontario
NCT07160231Recruiting· Phase 4
Lowering dose of JAK inhibitors for rheumatoid arthritis or psoriatic arthritis

This trial tests if reducing the dose of a JAK inhibitor can keep your inflammatory arthritis under control. If you have rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis and are in a stable remission, you may be able to take a lower dose.

Nijmegen, Gelderland
NCT06933134Recruiting
Using a biomarker to guide low-dose rituximab in rheumatoid arthritis

This trial aims to find out if a simple blood test (biomarker) can show whether a lower dose of rituximab will work for people with rheumatoid arthritis. If successful, it could help patients maintain good results with less medicine and fewer side effects.

Tours
NCT06072768Recruiting· Phase 2
Testing ways to safely lower steroid doses in rheumatoid arthritis

This study compares two different schedules for reducing prednisone (a steroid) in people with rheumatoid arthritis who are also taking another standard arthritis medicine. The goal is to find the safest and most effective way to taper off steroids without causing a flare-up.

Ann Arbor, Michigan

Hear when a new Rheumatoid Arthritis (RA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.